Awards & Advancement

Merck's biopharmaceutical division appoints Luciano Rossetti global head of R&D

Monday, July 14, 2014 12:59 PM

Merck's biopharmaceutical division has appointed Luciano Rossetti, M.D., executive vice president and global head of R&D as of July 21.

More... »


Scott Storrer to join Strand Life Sciences as president of North America

Friday, July 11, 2014 10:03 AM

Strand Life Sciences has added Scott Storrer, former president and CEO of Genomind, as Strand Life Sciences president of North America.

More... »

Subscribe to The CenterWatch Monthly

PPD wins awards for multimedia promoting the value of clinical trials

Friday, July 11, 2014 08:58 AM

CRO Pharmaceutical Product Development (PPD) has been recognized with awards for excellence in multimedia and digital communications that demonstrate the importance of clinical research in developing life-changing medical treatments. PPD recently earned four Telly Awards and three Web Health Awards.

More... »

Bellerophon Therapeutics names Jonathan Peacock chairman and CEO

Wednesday, July 2, 2014 11:37 AM

Bellerophon Therapeutics, a clinical stage biotherapeutics company, has announced that Jonathan Peacock has been appointed chairman and CEO. Peacock assumes the role from Daniel Tasse, chairman and CEO of Ikaria, who was interim chairman and CEO of Bellerophon since the company's spin-out from Ikaria in February. Tasse will continue as a member of the board of Bellerophon.

More... »

Jennifer Doudna, Emmanuelle Charpentier win award for biomedical research

Friday, June 27, 2014 12:53 PM

Johnson & Johnson has named Dr. Jennifer Doudna of the University of California at Berkeley and the Howard Hughes Medical Institute, and Dr. Emmanuelle Charpentier, of the Hannover Medical School and Helmholtz Center for Infection Research (HZI), Germany and the Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea University, Sweden, the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research. Their collaboration led to the discovery of a new method for precisely manipulating genetic information in ways that should produce new insights in health and disease, and may lead to the discovery of new targets for drug development.

More... »

St. Jude Children's Research Hospital names James R. Downing CEO

Friday, June 27, 2014 11:58 AM

St. Jude Children's Research Hospital has appointed James R. Downing, M.D., as its new CEO, effective July 15. Downing most recently was the deputy director, executive vice president and scientific director of the hospital. Downing's primary focus immediately upon assuming the CEO office will be to oversee a new era of clinical, research and infrastructure expansion throughout the St. Jude global network. He succeeds Dr. William E. Evans, who is retiring from the position after 10 years and returning full time to his long-standing pharmacogenomics research program at St. Jude.

More... »

HedgePath Pharmaceuticals adds three new board members

Thursday, June 26, 2014 03:36 PM

HedgePath Pharmaceuticals, a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, has announced that Stefan J. Cross, Dr. R. Dana Ono and W. Mark Watson, CPA, have been appointed to HedgePath's board of directors.

More... »

Kibow Biotech is a "Buzz of BIO" award winner

Thursday, June 19, 2014 02:52 PM

Kibow Biotech is winner of a 2014 BIO International Convention "Buzz of BIO Award," and is the first biotechnology company specializing exclusively in dietary supplement products to receive the honor during BIO's 29-year history. BIO is the world's largest trade association, representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and more than 30 other nations. BIO member companies are involved in the R&D of innovative healthcare, agricultural, industrial and environmental biotechnology products.

More... »

Sorbent Therapeutics appoints two new board members

Thursday, June 19, 2014 02:27 PM

Sorbent Therapeutics, a biopharmaceutical company developing therapies for cardiovascular and renal diseases, has appointed Jay Shepard and William D. Waddill to the company's board of directors.

More... »

Sangamo BioSciences appoints H. Stewart Parker to its board of directors

Thursday, June 19, 2014 01:57 PM

Sangamo BioSciences announced the appointment of H. Stewart Parker to the company's board of directors. Parker, who founded and was president and CEO of Targeted Genetics, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs